Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Elicio Therapeutics, Inc. (ELTX) had Tangible Shareholders Equity of $1.64M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-7.72M |
|
-- |
|
-- |
|
$8.84M |
|
$-8.84M |
|
$1.12M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
$-8.84M |
|
$-8.37M |
|
15.31M |
|
15.31M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$19.31M |
|
$0.29M |
|
$6.55M |
|
$25.86M |
|
$8.11M |
|
$9.41M |
|
$16.12M |
|
$24.23M |
|
$1.64M |
|
|
Tangible Shareholders Equity |
$1.64M |
$1.64M |
|
17.80M |
|
| Cash Flow Statement Financials | |
$-36.95M |
|
$-0.02M |
|
$36.70M |
|
$19.49M |
|
$19.27M |
|
$-0.23M |
|
$2.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
0.85 |
|
5.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-36.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-471.76% |
|
-471.76% |
|
-29.84% |
|
-69.89% |
|
$0.09 |
|
$-2.41 |
|
$-2.41 |
|